{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:08:44Z","timestamp":1790665724412,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23HL138154"],"award-info":[{"award-number":["K23HL138154"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001540","name":"CHEST Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["RAMOS17A0"],"award-info":[{"award-number":["RAMOS17A0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["LEASE16A3"],"award-info":[{"award-number":["LEASE16A3"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jcf.2022.04.009","type":"journal-article","created":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T07:20:37Z","timestamp":1650698437000},"page":"745-752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Use of elexacaftor\/tezacaftor\/ivacaftor among cystic fibrosis lung transplant recipients"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2309-368X","authenticated-orcid":false,"given":"Kathleen J.","family":"Ramos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0514-8536","authenticated-orcid":false,"given":"Jennifer S.","family":"Guimbellot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7454-0603","authenticated-orcid":false,"given":"Maryam","family":"Valapour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8329-3958","authenticated-orcid":false,"given":"Lauren E.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis Hee","family":"Wai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Goss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0893-1155","authenticated-orcid":false,"given":"Joseph M.","family":"Pilewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8408-6371","authenticated-orcid":false,"given":"Albert","family":"Faro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3695-4637","authenticated-orcid":false,"given":"Joshua M.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.jcf.2022.04.009_bib0001","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013tezacaftor\u2013ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"issue":"10212","key":"10.1016\/j.jcf.2022.04.009_bib0002","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet N Am Ed"},{"issue":"18","key":"10.1016\/j.jcf.2022.04.009_bib0003","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jcf.2022.04.009_bib0004","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1513\/AnnalsATS.201909-671CME","article-title":"The extrapulmonary effects of cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis","volume":"17","author":"Sergeev","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.jcf.2022.04.009_bib0005","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1038\/ctg.2017.10","article-title":"Impact of CFTR modulation on intestinal pH, motility, and clinical outcomes in patients with cystic fibrosis and the G551D mutation","volume":"8","author":"Gelfond","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"issue":"2","key":"10.1016\/j.jcf.2022.04.009_bib0006","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2522","article-title":"Growth in prepubertal children with cystic fibrosis treated with ivacaftor","volume":"139","author":"Stalvey","year":"2017","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.jcf.2022.04.009_bib0007","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/pedi.12026","article-title":"Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study","volume":"14","author":"Bellin","year":"2013","journal-title":"Pediatr Diabetes"},{"issue":"3","key":"10.1016\/j.jcf.2022.04.009_bib0008","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jcf.2020.07.002","article-title":"Effect of highly effective modulator treatment on sinonasal symptoms in cystic fibrosis","volume":"20","author":"DiMango","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2022.04.009_bib0009","doi-asserted-by":"crossref","first-page":"S375","DOI":"10.1016\/j.healun.2021.01.1057","article-title":"Elexacaftor\/ivacaftor\/tezacaftor in lung transplant recipients: a case series","volume":"40","author":"Potter","year":"2021","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.jcf.2022.04.009_bib0010","doi-asserted-by":"crossref","first-page":"e14007","DOI":"10.1111\/petr.14007","article-title":"To treat or not to treat: CFTR modulators after lung transplantation","volume":"25","author":"Hayes","year":"2021","journal-title":"Pediatr Transplant"},{"issue":"3","key":"10.1016\/j.jcf.2022.04.009_bib0011","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1164\/rccm.201806-1018OC","article-title":"Islet hormone and incretin secretion in cystic fibrosis after four months of ivacaftor therapy","volume":"199","author":"Kelly","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jcf.2022.04.009_bib0012","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcf.2021.09.001","article-title":"The effect of elexacaftor\/tezacaftor\/ivacaftor (ETI) on glycemia in adults with cystic fibrosis","volume":"21","author":"Scully","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2022.04.009_bib0013","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1513\/AnnalsATS.201807-449OC","article-title":"CFTR modulator use is associated with higher hemoglobin levels in individuals with cystic fibrosis","volume":"16","author":"Gifford","year":"2018","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"10.1016\/j.jcf.2022.04.009_bib0014","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1165\/rcmb.2011-0399RT","article-title":"Immune responses in cystic fibrosis: are they intrinsically defective?","volume":"46","author":"Ratner","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jcf.2022.04.009_bib0015","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3389\/fphar.2020.01219","article-title":"CFTR modulator therapy enhances peripheral blood monocyte contributions to immune responses in people with cystic fibrosis","volume":"11","author":"Hisert","year":"2020","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.jcf.2022.04.009_bib0016","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00318-2019","article-title":"Ivacaftor decreases monocyte sensitivity to interferon-\u03b3 in people with cystic fibrosis","volume":"6","author":"Hisert","year":"2020","journal-title":"ERJ Open Res"},{"issue":"4","key":"10.1016\/j.jcf.2022.04.009_bib0017","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1165\/rcmb.2015-0322LE","article-title":"Ivacaftor-induced proteomic changes suggest monocyte defects may contribute to the pathogenesis of cystic fibrosis","volume":"54","author":"Hisert","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.jcf.2022.04.009_bib0018","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/jcm10010023","article-title":"Real-world safety of CFTR modulators in the treatment of cystic fibrosis: a systematic review","volume":"10","author":"Dagenais","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.jcf.2022.04.009_bib0019","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1513\/AnnalsATS.202101-057OC","article-title":"Impact of cftr therapy on chronic rhinosinusitis and health status: deep learning ct analysis and patient reported outcomes","volume":"19","author":"Beswick","year":"2022","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.jcf.2022.04.009_bib0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1945892418815615","article-title":"Ivacaftor, a cystic fibrosis transmembrane conductance regulator potentiator, enhances ciprofloxacin activity against Pseudomonas aeruginosa","volume":"33","author":"Cho","year":"2019","journal-title":"Am J Rhinol Allergy"},{"issue":"1","key":"10.1016\/j.jcf.2022.04.009_bib0021","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000339627","article-title":"Impact of sinus surgery on pseudomonal airway colonization, bronchiolitis obliterans syndrome and survival in cystic fibrosis lung transplant recipients","volume":"86","author":"Vital","year":"2013","journal-title":"Respiration"},{"issue":"5","key":"10.1016\/j.jcf.2022.04.009_bib0022","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment-a consensus report from the Pulmonary council of the ISHLT","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.jcf.2022.04.009_bib0023","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/1945892419830624","article-title":"Decreased antibiotic utilization after sinus surgery in cystic fibrosis patients with lung transplantation","volume":"33","author":"Cheng","year":"2019","journal-title":"Am J Rhinol Allergy"},{"issue":"3","key":"10.1016\/j.jcf.2022.04.009_bib0024","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/lio2.401","article-title":"Chronic rhinosinusitis in patients with cystic fibrosis-current management and new treatments","volume":"5","author":"Johnson","year":"2020","journal-title":"Laryngoscope Investig Otolaryngol"},{"issue":"12","key":"10.1016\/j.jcf.2022.04.009_bib0025","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1681\/ASN.2007040394","article-title":"Chronic kidney disease after nonrenal solid-organ transplantation","volume":"18","author":"Bloom","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.jcf.2022.04.009_bib0026","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1183\/13993003.01444-2015","article-title":"Forecasting US ivacaftor outcomes and cost in cystic fibrosis patients with the G551D mutation","volume":"47","author":"Dilokthornsakul","year":"2016","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jcf.2022.04.009_bib0027","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s41030-021-00158-5","article-title":"Real-world long-term ivacaftor for cystic fibrosis in france: clinical effectiveness and healthcare resource utilization","volume":"7","author":"Hubert","year":"2021","journal-title":"Pulm Ther."},{"issue":"1","key":"10.1016\/j.jcf.2022.04.009_bib0028","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s41030-021-00154-9","article-title":"Long-term impact of ivacaftor on healthcare resource utilization among people with cystic fibrosis in the United States","volume":"7","author":"Thorat","year":"2021","journal-title":"Pulm Ther"},{"issue":"5","key":"10.1016\/j.jcf.2022.04.009_bib0029","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1164\/rccm.202108-1986OC","article-title":"Clinical effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis: a clinical trial","volume":"205","author":"Nichols","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.jcf.2022.04.009_bib0030","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jcf.2020.12.011","article-title":"Elexacafator\/tezacaftor\/ivacaftor resolves subfertility in females with CF: a two center case series","volume":"20","author":"O'Connor","year":"2021","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199322000984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199322000984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:14:28Z","timestamp":1778620468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199322000984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1569199322000984"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2022.04.009","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of elexacaftor\/tezacaftor\/ivacaftor among cystic fibrosis lung transplant recipients","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2022.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}